Brief: Esperion Therapeutics Inc European Commission Approved Label Update Of Both Nilemdo And Nustendi
22/05/2024 13:34
May 22 (Reuters) - Esperion Therapeutics Inc ESPR.O :
* ESPERION THERAPEUTICS INC: EUROPEAN COMMISSION APPROVED
LABEL
UPDATE OF BOTH NILEMDO AND NUSTENDI
Source text for Eikon: ID:nGNX9n6Fhl
Further company coverage: ESPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Esperion Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi